Whitehawk Therapeutics (WHWK) FCF Margin (QoQ) (2018 - 2025)

Whitehawk Therapeutics (WHWK) FCF Margin (QoQ) (2018 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Whitehawk Therapeutics 256.87 Mn 45.62 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 7,141.00
Dec 31, 2024 -4,119.00
Sep 30, 2024 -2,353.00
Jun 30, 2024 19,342.00
Mar 31, 2024 -21,401.00
Dec 31, 2023 3,461.00
Sep 30, 2023 8,717.00
Jun 30, 2023 9,748.00
Mar 31, 2023 -14,609.00
Dec 31, 2022 -3,548.00
Sep 30, 2022 13,067.00
Jun 30, 2022 52,365.00
Mar 31, 2022 -75,723.00
Mar 31, 2021 882,549.00
Dec 31, 2020 681,024.00
Sep 30, 2020 -690,185.00
Dec 31, 2018 -28.88 Mn
Sep 30, 2018 -101,660.00